1. Introduction {#s0005}
===============

Radix Isatidis (Banlangen or Bei-Banlangen in Chinese) is a traditional Chinese medicine (TCM) consisting of the dried root of *Isatis indigotica* Fort (Cruciferae). It was first recorded in *Shen Nong\'s Herbal classic* and has been used in China as an antipyretic and detoxifying herb for over 2000 years[@bib1], [@bib2]. Like many TCM, Radix Isatidis displays diverse pharmacological activities and exerts antibacterial[@bib3], [@bib4], [@bib5], antiviral[@bib6], [@bib7], [@bib8], [@bib9], [@bib10], antiinflammatory[@bib11], [@bib12], antitumor[@bib13], [@bib14], antiendotoxic[@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23] and immune regulatory effects[@bib24], [@bib25], [@bib26]. In fact, these effects have translated into pronounced clinical success in the treatment and/or prevention of influenza, tonsillitis and malignant infectious diseases[@bib27], [@bib28], [@bib29], [@bib30] particularly severe acute respiratory syndrome (SARS) and H1N1-influenza[@bib31], [@bib32], [@bib33]. It is now an established component of many TCM preparations such as Banlangen Granules and Qingkailing Injection which is widely used as antipyretic and antiviral drug in clinical practice.

The potent antiviral activity of Radix Isatidis is attributed to the presence of nucleosides which interfere in the gene expression of virus and thereby inhibit their proliferation and protect cells from virus damage[@bib34]. As a result, some water soluble compounds including glucosinolates (*R*,*S*-goitrin, progoitrin, epiprogoitrin and gluconapin) and nucleosides (hypoxanthine, adenosine, uridine and guanosine) have been investigated as potential indicators of the quality of Radix Isatidis and its finished products rather than non-polar components such as indigotin and indirubin[@bib35], [@bib36], [@bib37], [@bib38], [@bib39], [@bib40]. Recently, holistic chemical profiling of Radix Isatidis has been developed using HPLC[@bib41], [@bib42] to determine eight bioactive constituents, including 5 glucosinolates and 3 nucleosides[@bib43].

In this paper, a powerful strategy incorporating chemical fingerprinting and simultaneous quantitation has been developed for the quality assessment of Radix Isatidis. The method involving HPLC coupled with diode-array detection and electrospray ionization tandem mass spectrometry (HPLC--DAD--ESI/MS) was applied to evaluate the holistic qualities of commercially available Radix Isatidis from the herbal market in China. Chemical fingerprints based on the detection and simultaneous assay of five nucleosides and one glucosinolate were subjected to similarity analysis and partial least squares discrimination analysis (PLS-DA) to evaluate the technique. The validated method is expected to offer a more effective strategy to ensure consistent quality of Radix Isatidis.

2. Materials and methods {#s0010}
========================

2.1. Chemicals, reagents and plant materials {#s0015}
--------------------------------------------

Reference standards (batch numbers) and suppliers were as follows: uridine (887-200001), adenine (886-200001) and adenosine (110879-200202), National Institute for Food and Drug Control (Beijing, China); cytidine (200-610-9) and guanosine (G6752), Sigma-Aldrich (St. Louis, M.O., USA); *R*,*S*-goitrin (101103), Sichuan Victory Pharmaceutical Co., Ltd. (Chengdu, China). All standards were biochemical reagent grade (purities≥98%) as confirmed by HPLC.

HPLC-grade methanol was obtained from J.T. Baker. Ultrapure water (18.2 mΩ) daily prepared with a Milli-Q water purification system (Millipore, Molsheim, France) was used in the mobile phase. Other reagents were of analytical grade and used as received.

Twenty-five batches of Radix Isatidis from different geographical regions around China were obtained from three pharmaceutical companies producing the same TCM preparations using Radix Isatidis as raw material. All samples were morphologically authenticated by the authors and voucher specimens were deposited with the Department of Chemistry, Tsinghua University, Beijing, China.

2.2. Sample preparation {#s0020}
-----------------------

The root of *Isatis indigotica* Fort. were pulverized and approximately 0.5 g of ground sample accurately weighed and extracted by ultrasonication (44 kHz, 250 W) with 5 mL water for 20 min at room temperature. The extracts were then filtered through 0.2 μm PTFE syringe filters and 10 μL of each filtrate subjected to HPLC--DAD--ESI/MS analysis. Stock solutions (ca. 1.0 mg/mL) of the six reference compounds *viz* uridine, adenine, adenosine, cytidine, guanosine and *R*,*S*-goitrin were prepared in 50% methanol and stored at 4 °C until required. Equal volumes of these six stock solutions were mixed and diluted with 50% methanol to obtain a series of seven mixed standard solutions. The mixed standards were filtered through 0.2 μm PTFE syringe filters and 10 μL injected into the HPLC system.

2.3. HPLC--DAD analysis {#s0025}
-----------------------

HPLC was performed on an Agilent 1200 series system (Agilent Series 1200, Palo Alto, CA, USA) consisting of a binary pump, autosampler and diode array detector. After scanning in the range 200--400 nm, a wavelength of 254 nm was selected for qualitative and quantitative analysis. Chromatography was performed on a Phenomenex Luna C18 analytical column (250 mm×4.6 mm, 5 μm) at 25 °C using gradient elution at 0.8 mL/min of (A) water and (B) methanol according to the following program: 0--10 min 5% B; 10--25 min 5--15% B; 25--34 min 15--35% B; 34--40 min 35--95% B. The column was re-equilibrated for 10 min between individual runs.

2.4. Mass spectrometry {#s0030}
----------------------

Accurate mass determination to generate empirical formulae was performed on an Agilent 1100 Series LC/MSD TOF (Agilent Technologies Corp., Santa Clara, CA, USA) using electrospray ionization (ESI) in both positive (ESI^+^) and negative (ESI^−^) ion modes. HPLC effluent was introduced into the mass spectrometer with a post-column split of 3:1. Optimized ESI-MS parameters were: capillary voltage 3500 V (ESI^−^) or 4000 V (ESI^+^); drying gas 8.0 L/min; nebulizer pressure 40 psi; gas temperature 325 °C; fragmentor voltage 175 V (ESI^+^) and 190 V (ESI^−^); skimmer voltage 60 V; octopole dcl 37.5 V (ESI^+^) or 38.0 V (ESI^−^); octopole RF 250 V. Full-scan mass spectra were recorded in the range *m*/*z* 50--1500. Continuous calibration was maintained using reference masses of *m*/*z* 121.0509 and 922.0098. Analyst QS software (Applied Biosystems, Framingham, MA) was used to process mass data and to generate exact masses corresponding to particular elemental compositions. Instrument tuning was carried out daily using the tuning solution (G1969-85000, Agilent Corp, USA) to ensure a mass error \<5 ppm prior to sample analysis.

Fragmentation data for structure confirmation was generated on an Agilent 1100 Series HPLC instrument coupled to a 6300 series ion trap (G2445A, Agilent Technologies, Santa Clara, USA) *via* an ESI interface. The following operation parameters were used: capillary voltage 3500 V (ESI^−^) or 4000 V (ESI^+^); skimmer voltage 40 V; capillary exit voltage 137 V; nebulizer pressure 30 psi; drying gas 8 L/min; gas temperature 325 °C; target mass *m*/*z* 622; compound stability 100%; trap drive level 60%; threshold 50,000 (ESI^+^) and 10,000 (ESI^−^); ion charged control (ICC) on; target 10,000; accumulation time 200 ms. The amplitude voltage was generally 0.6 V for fragmentation in MS[@bib3] experiments. Data was processed by Agilent Chemstation Rev. A. 09.01 software (Agilent, Palo Alto, CA, USA).

2.5. Data analysis {#s0035}
------------------

Each sample solution was analyzed in triplicate and concentrations based on peak areas determined from the appropriate calibration curve. Identification of all marker compounds was based on a comparison of HPLC retention times, MS fragmentation pattern and UV spectra of peaks with data for corresponding standards. Similarity evaluation was performed using the Similarity Evaluation System for Chromatographic Fingerprinting of Traditional Chinese Medicines (Version 2004A) published by the Chinese Pharmacopoeia Committee. The software mainly uses the correlation coefficient for evaluating the similarities of different chromatograms[@bib44]. Partial least squares discrimination analysis (PLS-DA) was performed using SIMCA-P (version 12.0, Demo).

3. Results and discussion {#s0040}
=========================

3.1. Optimization of HPLC conditions {#s0045}
------------------------------------

Column type, mobile phase composition, gradient elution program, flow rate and column temperature were optimized to achieve maximum resolution in the minimum run time. The detection wavelength for quantitative analysis was selected as 254 nm at which all marker components showed absorption. Representative HPLC chromatograms of Radix Isatidis are shown in [Fig. 1](#f0005){ref-type="fig"}.Figure 1Typical chromatograms of (A) a mixed standard solution and (B) an aqueous extract of Radix Isatidis showing peaks from six bioactive compounds. 1, cytidine; 2, uridine; 3, adenine; 4, guanosine; 5, *R*,S-goitrin; 6, adenosine.

3.2. Optimization of extraction method {#s0050}
--------------------------------------

Considering the analytes of interest are relatively polar, aqueous methanol was predicted and found to be a suitable extraction solvent. Extraction conditions including extraction method (reflux or ultrasonication), number of extractions (1, 2 or 3), methanol concentration (0%, 25%, 50%, 75% and 100% *v*/*v*) and extraction time (20, 40 and 60 min) were investigated to give the maximum number of peaks in the HPLC fingerprint. Finally, the extraction method presented in [Section 2.2](#s0020){ref-type="sec"} was selected.

3.3. Identification of marker compounds {#s0055}
---------------------------------------

HPLC-UV and LC--ESI/MS analysis of the aqueous extract of Radix Isatidis (Sample 1) showed six peaks ([Fig. 1](#f0005){ref-type="fig"}) which were characterized by the online UV spectra. These showed maximum absorption at 260--270 nm for nucleosides and 245--252 nm for the glucosinolate. By comparing retention times, UV spectra, *m*/*z* of characteristic molecular ions, empirical molecular formulae and low-energy collision induced dissociation fragment ions with those produced by authentic standards, the compounds corresponding to Peaks 1--6 were identified as cytidine, uridine, adenine, guanosine, *R*,*S*-goitrin and adenosine, respectively. The characteristics of these six compounds are given in [Table 1](#t0005){ref-type="table"} which shows that mass accuracy for all molecular ions, quasi-molecular ions and fragment ions was \<30 ppm. This indicates that the empirical molecular formulae were well matched to the putative deprotonated ions, quasi-molecular ions and fragment ions.Table 1Components identified in samples of Radix Isatidis.Compound No.*t*~R~ (min)Identification[a](#tbl1fna){ref-type="table-fn"}UV(*λ*~max~, nm)MS Selected ionFormulaMeasured massCalculated massMass accuracy (ppm)MS (pos/neg ionization)MS (*m/z*)MS[@bib2] (*m/z*)18.3Cytidine236(sh), 270\[M+H\]^+^C~9~H~14~N~3~O~5~244.0925244.0927−1.2175242.8\[M−H\]^−^199.7\[M−H−HNCO\]^−^213.5Uridine260\[M−H\]^−^C~9~H~11~N~2~O~6~243.0672243.061124.8378242.9\[M−H\]^−^199.9\[M−H−HNCO\]^−^321.0Adenine260\[M+H\]^+^C~5~H~6~N~5~136.0625136.06175.3526136.0\[M+H\]^+^425.0Guanosine250, 280 (sh)\[M+H\]^+^C~10~H~14~N~5~O~5~284.0982284.1046−2.6231281.9\[M−H\]^−^194.8\[M−H−C~2~N~3~HO\]^−^528.1*R,S*-Goitrin245\[M+H\]^+^C~5~H~7~NOS130.0340130.015114.5177130.0\[M+H\]^+^633.6Adenosine260\[M+H\]^+^C~10~H~14~N~5~O~4~268.1089268.10402.1238268.1\[M+H\]^+^136.0\[M−C~4~H~4~O~3~\]^+^[^1]

3.4. Assay validation for quantitation {#s0060}
--------------------------------------

The quantitative HPLC method was validated by defining linearity, limit of quantitation (LLOQ) and limit of detection (LOD), repeatability, accuracy and precision and stability. Linearity was assessed by linear regression of calibration curves for each analyte. The regression equations, correlation coefficients and linear ranges for six marker compounds are shown in [Table 2](#t0010){ref-type="table"}. The LOD and LLOQ, calculated as the concentrations giving signal-to-noise ratios of 3 (*S*/*N*=3) and 10 (*S*/*N*=10) respectively, are also listed in [Table 2](#t0010){ref-type="table"}.Table 2Calibration curves and detection limits (LOD and LLOQ) for the six marker compounds in Radix Isatidis.CompoundCalibration curve[a](#tbl2fna){ref-type="table-fn"}*r*Linear range (mg/mL)LOD[b](#tbl2fnb){ref-type="table-fn"}(ng)LLOQ[b](#tbl2fnb){ref-type="table-fn"}(ng)Cytidine (**1**)*Y*=19573*X*+2.58720.99983.4×10^--3^--11.0×10^--2^0.341.13Uridine (**2**)*Y*=24259*X*+41.8700.99944.7×10^--3^--15.0×10^--2^0.441.47Adenine (**3**)*Y*=65688*X*−19.2860.99981.7×10^--3^--5.33×10^--2^0.561.88Guanosine (**4**)*Y*=32675*X*−7.34380.99984.3×10^--3^--13.6×10^--2^0.341.15*R*,S-Goitrin (**5**)*Y*=26506*X*−571.990.999623.7×10^--3^--75.5×10^--2^0.752.50Adenosine (**6**)*Y*=39284*X*−4.10871.0002.4×10^--3^--7.71×10^--2^0.331.09[^2][^3]

Intra- and inter-day precision were determined by assay of six replicate extracts of a powdered Radix Isatidis sample on one day and assay of the same six extracts on three separate days respectively. Intra- and inter-day precision (as relative standard deviation RSD) were found to be \<0.76% and \<2.19%, respectively. Accuracy (recovery) was determined by assay of an extract spiked in triplicate with low, medium and high concentrations of the mixed standard solution. Accuracy was found to be in the range 98.6%--101.5% with an RSD of 1.24%--2.98% ( [Table 3](#t0015){ref-type="table"}). Stability was assessed by measuring peak areas of the six compounds initially and after 4, 8, 12, 16 and 24 h at room temperature. Variation in peak area of the six compounds was \<3.0%. These results indicate that the HPLC method is precise, accurate and sensitive for quantitative determination of the nucleosides and glucosinolates in Radix Isatidis samples.Table 3Accuracy of HPLC-UV method for the determination of six marker compounds.CompoundOriginal (μg)Spiked (μg)Found (μg)Recovery (%)RSD (%)Cytidine (**1**)5.984.7910.76101.251.775.6211.737.3613.47  Uridine (**2**)9.767.3217.16101.531.599.5619.4711.9121.89  Adenine (**3**)5.494.5010.13100.952.975.7611.136.4812.07  Guanosine (**4**)5.804.5210.2899.812.945.6011.526.9612.61  *R*,*S*-Goitrin (**5**)58.9745.41103.9999.301.2461.92120.6670.18128.54  Adenosine (**6**)2.992.335.3398.982.983.236.113.686.65

3.5. Chemical profiling and quantitation {#s0065}
----------------------------------------

Chemical profiling and assay of 25 samples of Radix Isatidis from different geographical regions of China were carried out. [Fig. 2](#f0010){ref-type="fig"} presents typical HPLC chromatograms of their aqueous extracts.Figure 2HPLC fingerprints of 25 samples of Radix Isatidis and the reference standard fingerprint generated by similarity evaluation software based on identification and quantitation of six compounds. 1, cytidine; 2, uridine; 3, adenine; 4, guanosine; 5, *R*,*S*-goitrin; 6, adenosine.

The State Food and Drug Administration (SFDA) suggests that chromatograms of herbal samples should be evaluated in terms of similarity by calculating the correlation coefficient and/or angle cosine value of the original data. A representative fingerprint of Radix Isatidis was generated for all samples using the software of the Similarity Evaluation System and the peak from *R*,*S*-goitrin as reference. As shown in [Fig. 3](#f0015){ref-type="fig"}, all samples showed average similarity of 0.928. The chemical constituents in samples from company A (samples 1--10) and B (samples 11--15) were significantly different within groups with similarities in the ranges 0.729--0.986 and 0.751--0.976, respectively, while those in samples from company C (samples 16--25) exhibited satisfactory consistency within the group with a similarity in the range 0.959--0.993. The fingerprints were also subjected to PLS-DA which showed the samples from different companies were well separated by PLS-DA with variability in the contents of the six marker components ( [Fig. 4](#f0020){ref-type="fig"}). Thus the results of PLS-DA and similarity analysis are consistent. In the scatter plot, samples from companies A and B were more discrete than those of company C (only sample 25 was shown to be an outlier) suggesting the quality of the Radix Isatidis samples sourced from company C were more stable.Figure 3Similarity evaluation of the HPLC fingerprints of 25 Radix Isatidis samples classified into three groups (A, B and C) based on the three pharmaceutical companies from which they were sourced.Figure 4Discrimination analysis based on a PLS-DA plot of the fingerprints of 25 samples of Radix Isatidis generated by SIMCA-P (version 12.0, Demo). Samples are classified into three groups (A, B and C) based on the three pharmaceutical companies from which they were sourced.

The content (mg/g) of the six marker compounds in the 25 samples of Radix Isatidis is shown in [Table 4](#t0020){ref-type="table"}. All samples contained all six compounds. The content of *R*,*S*-goitrin was in the range 0.36--4.50 mg/g which is higher than the defined limit of 0.2 mg/g set by the Chinese Pharmacopoeia. This means that all samples qualified as crude material. However, as shown in [Fig. 5](#f0025){ref-type="fig"}, significant differences exist in the content of the six marker compounds particularly for *R*,*S*-goitrin where the contents showed an RSD of 66%. Such significant differences in the content of chemical constituents would likely be associated with variable quality and uncertain therapeutic efficacy of this herb and the TCM which include it.Table 4Content (mg/g) of six marker compounds in 25 samples of Radix Isatidis.Batch no.Sample items[a](#tbl4fna){ref-type="table-fn"}Content[b](#tbl4fnb){ref-type="table-fn"} (mg/g)CytidineUridineAdenineGuanosine*R*,*S*-GoitrinAdenosineTotal120502A0.240.270.070.272.820.323.98120501A0.150.310.040.270.670.391.83120516A0.120.290.030.221.200.242.10120503A0.310.340.130.444.500.215.92120518A0.270.420.080.371.280.302.72120519A0.190.280.040.301.280.292.39120514A0.160.230.040.252.320.273.27120507A0.260.420.060.370.360.361.84120602A0.230.350.040.330.650.311.91120509A0.280.360.060.360.680.342.09120401B0.250.510.060.510.520.652.50120501B0.490.700.080.800.570.713.33120602B0.450.670.080.750.590.633.19120601B0.490.710.100.610.730.473.11110503B0.250.350.040.353.930.465.38110317C0.150.290.040.211.350.212.26110209C0.150.300.040.211.430.222.36110216C0.140.280.040.181.560.192.39110304C0.170.310.090.211.900.142.81110213C0.190.320.050.211.610.202.58110220C0.170.320.050.221.980.232.97110225C0.190.340.060.201.640.202.62110228C0.170.300.040.242.690.223.67110223C0.170.300.060.201.780.192.71110307C0.270.390.210.403.230.024.52  Min0.120.230.030.180.360.021.83Max0.490.710.210.804.500.715.92Average0.240.370.070.341.650.312.98SD (*n*=25)0.100.130.040.171.090.161.04[^4][^5][^6]Figure 5Comparison of the average content (mg/g) of the six marker compounds in 25 samples of Radix Isatidis classified into three groups (A, B and C) based on the three pharmaceutical companies from which they were sourced.

4. Conclusions {#s0070}
==============

HPLC fingerprint analysis was used to evaluate the quality and consistency of 25 samples of Radix Isatidis sourced from different regions of China and used by three pharmaceutical companies to make various TCM preparation. Fingerprints were based on the simultaneous identification and quantitation of five nucleosides and one glucosinolate. Similarity analysis was used to compare the fingerprints and demonstrate the consistency of the groups of samples sourced from the three companies. The method was shown to provide an effective quality evaluation strategy to ensure the consistent quality of Radix Isatidis.
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[^1]: Compared with authentic compounds.

[^2]: *Y* is peak area; *X* is concentration (mg/mL) of analytes.

[^3]: The LOD and LLOQ are defined as the concentrations that can be detected at *S*/*N* ratios of 3 and 10 respectively.

[^4]: All samples were morphologically authenticated as Radix Isatidis according to the current standard of the *Chinese Pharmacopoeia*.

[^5]: Sample item A, B and C refers to the three pharmaceutical companies from which the samples were sourced.

[^6]: Values are in mg/g of dry raw material and expressed as mean±SD, *n*=3; the SD was \<4%.
